Effect of probucol treatment on malondialdehyde-modified low-density lipoproteins in type 2 diabetic patients with hypercholesterolemia.

被引：0
|
作者：
Iijima, H [1 ]
Sato, N [1 ]
Motohashi, S [1 ]
Kase, H [1 ]
Kawagoe, Y [1 ]
Matsumura, M [1 ]
Atsuta, H [1 ]
Enomoto, M [1 ]
Kato, T [1 ]
Mochizuki, Y [1 ]
Kanazawa, H [1 ]
Kuroda, H [1 ]
Bannba, N [1 ]
Hattori, Y [1 ]
Kasai, K [1 ]
机构：
[1] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi, Japan
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229
引用
收藏
页码：A320 / A320
页数：1
相关论文
共 50 条
  • [21] SERUM MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEIN LEVEL IS A RISK FOR AORTIC STIFFNESS IN MAINTENANCE HEMODIALYSIS PATIENTS
    Hou, Jia-Sian
    Lu, Chia-Wen
    Hsu, Bang-Gee
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1589 - 1589
  • [22] Associations of circulating malondialdehyde-modified low-density lipoprotein with lipoprotein subclasses in healthy men
    Takahashi, R.
    Okumura, K.
    Yoshikane, M.
    Ikeda, N.
    Murohara, T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 211 - 211
  • [23] Modification of low-density lipoproteins in diabetic patients
    Beatriz De Marco, Catalina
    Elena Scoccia, Adriana
    Carmen Apezteguia, Maria
    Bruzzone, Liliana
    Beatriz Etcheverry, Susana
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2009, 43 (04): : 579 - 587
  • [24] Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus
    Kotani, Kazuo
    Tashiro, Jun
    Yamazaki, Kenya
    Nakamura, Yoshitake
    Miyazaki, Akira
    Bujo, Hideaki
    Saito, Yasushi
    Kanno, Takashi
    Maekawa, Masato
    CLINICA CHIMICA ACTA, 2015, 450 : 145 - 150
  • [25] Effect of febuxostat on the level of malondialdehyde-modified low-density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study
    Teragawa, Hiroki
    Tanaka, Atsushi
    Fujii, Yuichi
    Yoshida, Hisako
    Ueda, Tomohiro
    Nomura, Shuichi
    Kadokami, Toshiaki
    Koide, Hisashi
    Saito, Makoto
    Sano, Hiroaki K.
    Bando, Yasuko
    Murohara, Toyoaki
    Node, Koichi
    PRIZE Study Investigators
    CLINICAL CARDIOLOGY, 2023, 46 (06) : 698 - 706
  • [26] Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients
    Hou, Jia-Sian
    Wang, Chih-Hsien
    Lai, Yu-Hsien
    Kuo, Chiu-Huang
    Lin, Yu-Li
    Hsu, Bang-Gee
    Tsai, Jen-Pi
    NUTRIENTS, 2020, 12 (07) : 1 - 10
  • [27] Serum Malondialdehyde-Modified Low-Density Lipoprotein as a Risk Marker for Peripheral Arterial Stiffness in Maintenance Hemodialysis Patients
    Liu, Wei-Nung
    Hsu, Yi-Chiung
    Lu, Chia-Wen
    Lin, Ssu-Chin
    Wu, Tsung-Jui
    Lin, Gen-Min
    MEDICINA-LITHUANIA, 2024, 60 (05):
  • [28] Circulating oxidized low-density lipoproteins and antibody to oxidized low-density lipoproteins in Type 2 diabetic subjects: the role of glycoxidation
    Sartore, G
    Piarulli, F
    Lapolla, A
    Cantaro, S
    Reitano, R
    Fiore, C
    Marin, R
    Bassan, S
    Piconi, L
    Manzato, E
    Fedele, D
    DIABETOLOGIA, 2004, 47 : A412 - A412
  • [29] Circulating malondialdehyde-modified low-density lipoprotein is strongly associated with very small low-density lipoprotein cholesterol concentrations in healthy men
    Takahashi, Ryotaro
    Imamura, Akiko
    Yoshikane, Mari
    Suzuki, Masayuki
    Cheng, Xian Wu
    Numaguchi, Yasushi
    Ikeda, Nobuo
    Murohara, Toyoaki
    Okumura, Kenji
    CLINICA CHIMICA ACTA, 2009, 399 (1-2) : 74 - 78
  • [30] Malondialdehyde-Modified Low-Density Lipoprotein to High-Density Lipoprotein Cholesterol Ratio Predicts Endothelial Dysfunction
    Sugiura, Tomonori
    Dohi, Yasuaki
    Yamashita, Sumiyo
    Yamamoto, Koji
    Wakamatsu, Yoshimasa
    Tanaka, Satoru
    Takeda, Yutaka
    Ohte, Nobuyuki
    Kimura, Genjiro
    CIRCULATION, 2010, 122 (21)
12345